crenolanib-resistant FLT3 mutants
Daver N, Schlenk RF, Russell NH, Levis MJ. Targeting FLT3 mutations in AML: review of current knowledge and evidence. Leukemia. 2019 Jan 16;33(2):299–312. doi: 10.1038/s41375-018-0357-9.; Staudt D, Murray HC, McLachlan T, Alvaro F, Enjeti AK, Verrills NM, Dun MD. Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance. Int J Mol Sci. 2018 Oct 16;19(10). PMID: 30332834; PMCID: PMC6214138.; Larrosa-Garcia M, Baer MR. FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions. Mol Cancer Ther. 2017 Jun;16(6):991–1001. PMID: 28576946; PMCID: PMC5600895.